Online Program

Six big ideas: Overview of the sacim's recommendations for infant mortality

Tuesday, November 5, 2013 : 12:35 p.m. - 12:50 p.m.

Kay Johnson, MPH, EdM, Johnson Group Consulting, Hinesburg, VT
In 2010, the U.S. ranked 24th in infant mortality compared to other industrialized nations of the world. Infant mortality is a reflection of a society's commitment to ensuring access to health care, adequate nutrition, a healthy psychosocial and physical environment, and sufficient income to prevent the adverse consequences of poverty. While progress has been made in reducing U.S. infant mortality rates, the nation must do more to address not only the overall number of infant deaths, but also the disproportionate burden of infant mortality shouldered by racial/ethnic minorities and the poor. In June, 2012, Health and Human Services (HHS) Secretary Kathleen Sebelius made a commitment to the development of the nation's first national strategy to reduce infant mortality. She subsequently asked her Advisory Committee on Infant Mortality (SACIM) to make recommendations to serve as the framework for an official federal action plan. This session will present an overview of SACIM's charge, process, and recommendations as presented to the Secretary in November 2012. The Secretary's response, key developments, and aims for moving forward also will be discussed. (N=169)

Learning Areas:

Provision of health care to the public

Learning Objectives:
List core principles that guided SACIM’s recommendations for a national strategy Identify the 2015 and 2020 infant mortality targets that SACIM recommends based on recent trends Discuss the “6 Big Ideas” or strategic directions that constitute SACIM’s framework for a national strategy on infant mortality

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a Research Asssitant Professor in the Department of Pediatrics at Dartmouth Medical School and the President of the Johnson Group Consulting Services. Based on my experiences in these positions, I have several years of experience on the issue of infant mortality.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.